QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
Tesaro, Inc.
Trishula Therapeutics, Inc.
The Netherlands Cancer Institute
IGM Biosciences, Inc.
Karyopharm Therapeutics Inc
Eli Lilly and Company
Biosplice Therapeutics, Inc.
Cantargia AB
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Emory University